glp-1 law suit Judicial Panel Authorizes New Vision Loss Litigation Lipsitz, Ponterio & Comerford |

Two studies from Denmark [32, 36], using a grace period of 90 days (as was done in our main analyses), reported that approximately 20% of both GLP-1 receptor agonist users [32, 36] and SGLT2 inhibitor users [32] had discontinued treatment within 1 year of treatment initiation

Neurofeedback with anxiety and affective disorders

Silvestre R, et al

These decisions continue to have major implications on which corner of the life sciences tools and services space captures the most value: do the large bioprocessing platform players (e.g., Thermo Fisher, Cytiva, Sartorius) see an uplift, or do the specialized peptide synthesis equipment vendors and CDMOs benefit most (e.g., CEM Corporation, AAPPTec, Bachem, PolyPeptide)

Now, McDaniels loves a 9 a.m

The level of ongoing physician oversight can vary depending on the membership plan and individual provider